Recently, it is found that circFGFR1 may act as a sponge for miR-381-3p, thereby promoting NSCLC progression and resistance to anti-PD-1 therapy by up-regulating CXCR4 expression. This evidence concerns the gene PDCD1 and non-small cell lung carcinoma.